Detalles de la búsqueda
1.
Top 10 Challenges in Cancer Immunotherapy.
Immunity;
52(1): 17-35, 2020 01 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31940268
2.
TGFß attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.
Nature;
554(7693): 544-548, 2018 02 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29443960
3.
Genomic Profiling Reveals Differences in Primary Central Nervous System Lymphoma and Large B-Cell Lymphoma, With Subtyping Suggesting Sensitivity to BTK Inhibition.
Oncologist;
28(1): e26-e35, 2023 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36342081
4.
A Novel HRD Signature Is Predictive of FOLFIRINOX Benefit in Metastatic Pancreatic Cancer.
Oncologist;
28(8): 691-698, 2023 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37354528
5.
Suppressing neutrophil-dependent angiogenesis abrogates resistance to anti-VEGF antibody in a genetic model of colorectal cancer.
Proc Natl Acad Sci U S A;
117(35): 21598-21608, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32817421
6.
Association of CD274 (PD-L1) Copy Number Changes with Immune Checkpoint Inhibitor Clinical Benefit in Non-Squamous Non-Small Cell Lung Cancer.
Oncologist;
27(9): 732-739, 2022 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35598202
7.
Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: An Exploratory Analysis from the PREDATOR Study of Metastatic Colorectal Cancer (mCRC) Patients Undergoing Surgical Resection.
Int J Mol Sci;
23(19)2022 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36232827
8.
A pan-cancer analysis of PD-L1 immunohistochemistry and gene amplification, tumor mutation burden and microsatellite instability in 48,782 cases.
Mod Pathol;
34(2): 252-263, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32884129
9.
Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1).
Proc Natl Acad Sci U S A;
115(43): E10119-E10126, 2018 10 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-30297397
10.
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer.
Nature;
515(7528): 558-62, 2014 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-25428503
11.
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.
Nature;
515(7528): 563-7, 2014 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-25428504
12.
Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeutics.
Semin Cancer Biol;
52(Pt 2): 117-124, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29229461
13.
Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial.
Lancet;
391(10122): 748-757, 2018 02 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-29268948
14.
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.
Lancet;
389(10064): 67-76, 2017 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27939400
15.
Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First-Line Nonsquamous Non-Small Cell Lung Cancer.
Oncologist;
23(6): 654-e58, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29438092
16.
Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer.
Oncologist;
22(4): 375-e30, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28275117
17.
Profiling cancer gene mutations in clinical formalin-fixed, paraffin-embedded colorectal tumor specimens using targeted next-generation sequencing.
Oncologist;
19(4): 336-43, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24664487
18.
A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors.
Invest New Drugs;
32(4): 653-60, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24604265
19.
Analytical validation of a novel comprehensive genomic profiling informed circulating tumor DNA monitoring assay for solid tumors.
PLoS One;
19(5): e0302129, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38753705
20.
Development of a robust flow cytometry-based pharmacodynamic assay to detect phospho-protein signals for phosphatidylinositol 3-kinase inhibitors in multiple myeloma.
J Transl Med;
11: 76, 2013 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-23522020